Characteristics | RA (total) | Anti-CCP- | Anti-CCP+ | RF- | RF+ | p- value |
---|---|---|---|---|---|---|
(n = 30) | (n = 9) | (n = 21) | (n = 12) | (n = 18) | ||
Gender (%) | Â | Â | Â | Â | Â | Â |
 Women | 28 (93.3 %) | 8 (89 %) | 20 (95 %) | 11 (92 %) | 17 (94 %) | >0.05* |
 Men | 2 (6.66 %) | 1 (11 %) | 1 (5 %) | 1 (8 %) | 1 (6 %) |  |
Age (years) | 50.47 ± 9.9 | 51.6 ± 10.2 | 50 ± 10.1 | 52.3 ± 10.4 | 49.3 ± 9.7 | >0.05# |
Time since diagnosis (years) | 6 ± 2.8 | 5 ± 2.9 | 6 ± 2.4 | 6 ± 2.3 | 6 ± 1.8 | >0.05+ |
Education (years) | 7.9 ± 2.9 | 6.6 ± 1.4 | 8.5 ± 3.1 | 8.0 ± 3.2 | 7.9 ± 2.5 | <0.05## |
Physical activity | 12 (40Â %) | 5 (55.6Â %) | 7 (33.3Â %) | 6 (50Â %) | 6 (33.3Â %) | >0.05** |
Smoking (%) | 7 (23.3Â %) | 2 (22.2Â %) | 5 (23.8Â %) | 2 (16.7Â %) | 5 (27.8Â %) | >0.05* |
Treatment (%) | Â | Â | Â | Â | Â | Â |
 Synthetic DMARD | 21 (70 %) | 7 (77.7 %) | 14 (66.6 %) | 9 (75 %) | 13 (72.2 %) | >0.05* |
 Biologic DMARD | 9 (30 %) | 2 (22.20 %) | 7 (33.3 %) | 3 (25 %) | 5 (27.7 %) | >0.05* |
DAS 28 | 3.47 ± 0.5 | 3.7 ± 0.3 | 3.36 ± 0.6 | 3.6 ± 0.5 | 3.4 ± 0.5 | >0.05+ |
HAQ | 0.84 ± 0.4 | 0.9 ± 0.4 | 0.8 ± 0.4 | 0.9 ± 0.4 | 0.8 ± 0.4 | >0.05+ |
Radiographic erosions at initial evaluation (%) | 16 (53.3Â %) | 2 (22.2Â %) | 14 (66.6Â %) | 5 (41.7Â %) | 13 (72.2Â %) | <0.05** |